Expanding U.S. BioPharma to Europe: Strategies for Success

This by-invitation-only event will bring together a select group of life sciences executives to discuss best practices and strategies for U.S. companies looking to successfully expand into the European market. Among our esteemed guest speakers, we are delighted to include executives from Blueprint Medicines, who have successfully established operations across Europe and brought forward a rare disease medicine through the complex European market access and pricing environment.  Besides the access & pricing challenges, we will also touch on some HR topics like timelines of hiring, and competitiveness of the market for top talents. Our speakers will share their valuable experiences and insights, while also engaging in an open debate about the opportunities available for U.S. biotech companies aiming to establish a presence in Europe.